The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Response rate and toxicity of primary concomitant radio-chemotherapy in locally advanced cervical cancer: Results of an open prospective, multicenter phase II study of the NOGGO.
A. Mustea
No relevant relationships to disclose
A. Belau
No relevant relationships to disclose
J. Sehouli
No relevant relationships to disclose
K. Drzewiecki
No relevant relationships to disclose
M. H. R. Eichbaum
No relevant relationships to disclose
K. Bartz
No relevant relationships to disclose
E. Angelidou
No relevant relationships to disclose
S. Saegner
No relevant relationships to disclose
M. O. Langenbruch
No relevant relationships to disclose
P. Ledwon
No relevant relationships to disclose
M. Zygmunt
No relevant relationships to disclose
G. Koehler
No relevant relationships to disclose
D. Koensgen
No relevant relationships to disclose